The PI3K/mTOR dual inhibitor NVP‐BEZ235 stimulates mutant p53 degradation to exert anti‐tumor effects on triple‐negative breast cancer cells

by Jiajing Cai, Jingruo Xia, Jiang Zou, Qiang Wang, Qiang Ma, Ru Sun, Hebin Liao, Lei Xu, Dongsheng Wang, Xiaolan Guo
Published 2020-04-01